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ABSTRACT: Brucellosis is of great public health and economic
importance worldwide. Detection of brucellosis currently relies on
serologic testing of an antibody response to Brucella infection, which
suffers from cross-sensitivities to other antibody responses. Here we
present a new method for identifying Brucella exposure that is based
on profiling volatile organic compounds (VOCs) in exhaled breath.
Breath samples from Brucella-seropositive bison and controls were
chemically analyzed and demonstrated statistically significant differ-
ences in the concentration profiles of five VOCs. A point-of-care
device incorporating an array of nanomaterial-based sensors could
identify VOC patterns indicative of Brucella exposure with excellent
discriminative power, using a statistical algorithm. We show that the patterns were not affected by the animals’ environment and
that the discriminative power of the approach was stable over time. The Brucella-indicative VOCs and collective patterns that
were identified in this pilot study could lead to the development of a novel diagnostic screening test for quickly detecting infected
animals chute-side, pen-side, or even remotely in populations of free-ranging ungulates. The promising preliminary results
presented encourage subsequent larger scale trials in order to further evaluate the proposed method.
Brucellosis, caused by bacteria of the genus Brucella, is azoonotic disease of livestock that is of great public health
and economic importance worldwide.1 This disease results in
annual losses of approximately 1 million dollars in the United
States alone.1 In domestic cattle (Bos taurus), Brucella abortus is
the causative agent. However, other mammalian species are
susceptible to B. abortus infection as well. In the United States,
B. abortus was likely introduced to bison (Bison bison) and elk
(Cervus elaphus) populations in the Greater Yellowstone Area
(GYA) through cattle at the beginning of the 20th century.
While national eradication campaigns have all but eliminated
cattle brucellosis from the country, wild elk and bison herds of
the GYA still maintain the disease and are potential
transmission sources for domestic cattle sharing the range
with wildlife.2
Ante-mortem detection of brucellosis currently relies on
blood collection and serologic testing of animals and therefore
depends on an antibody response to infection. Additionally,
cross-reactivity of the serological tests to antibodies against
other organisms, such as Yersinia enterocolitica O:9, can occur.
Hence, there is a need for a less invasive, more accurate
technique to detect Brucella infection. Ideally, this technique
would allow remote detection of Brucella infection in wild
animals.
The detection of disease-associated volatile organic com-
pounds (VOCs), or patterns thereof, from exhaled breath3−8
may provide an efficient and accurate solution for identifying
infectious diseases in both domestic and wild animal
populations.9 Volatile organic compounds are currently being
explored for detection of various disease processes.3−8 In the
case of infectious diseases, unique VOC combinations and
concentrations may be present in various host-derived
biological products or tissues and may result from the
interactions between host and agent.9 For example, VOC
pattern differences could be detected in the headspace of serum
samples collected from populations of brucellosis-infected and
healthy cattle, using an array of conductive polymer sensors.10
A nanomaterial-based sensor array developed by Haick and
co-workers has been proven useful for identifying diseases in
humans and livestock based on analysis of VOC profiles in
exhaled breath samples, including infectious diseases,9,11 renal
disease,12−14 neurodegenerative diseases,15,16 and different
types of cancer.17−20 In particular, Peled et al.9 found that
cattle with bovine tuberculosis could be identified using a
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nanomaterial-based breath test. In this paper we explored VOC
concentration profiles in exhaled breath samples collected from
bison naturally infected or exposed to B. abortus, using methods
of quantitative chemical gas analysis. We then tested the
discriminative power of a point-of-care diagnostic method that
utilized an array of nanomaterial-based sensors combined with
a statistical data-analysis algorithm and its insensitivity against
changes in the local environment of the tested animals. The
stability of the process over time was verified in a follow-up
sampling event of one of the previously tested cohorts.
■ EXPERIMENTAL SECTION
Animals. A total of 38 female bison were used for this study.
Seventeen bison were housed in the United States Department
of Agriculture (USDA)/Animal Plant Health Inspection
Service (APHIS)/Animal Population Health Institute/Wildlife
Research Facility (WRF) in Fort Collins, Colorado. Nine of
these animals originated from a Brucella-infected herd in
Wyoming and were identified as seropositive for B. abortus on
standard tests. These animals had been housed at the WRF for
17 months. The remaining eight bison served as negative
controls, were members of a commercial herd that was acquired
for another research project, and had been on the premises for
7 months. Twenty-one bison were housed at the USDA/
APHIS Bison Quarantine Facility (BQF) in Corwin Springs,
Montana and were also part of an immunocontraception
vaccine study. These bison had been captured and transported
from Yellowstone National Park in April, 2012. In total, 11
bison in this cohort were seropositive for B. abortus; 10 bison
were seronegative and served as negative controls. In July 2012,
they were divided and transported to Site 1 and Site 2, which
were approximately 11 km to the north of the BQF site, and
approximately 1 mile apart. Five seropositive and five
seronegative bison were held at Site 1. Six seropositive and
five seronegative bison were held at Site 2. The six seropositive
animals at Site 2 had been vaccinated with a GnRH
immunocontraceptive vaccine after the first sampling in May
2012. All animal work, including the peripheral studies, was
approved by the Institutional Animal Care and Use
Committees of the Bison Quarantine Feasibility Study and
Colorado State University.
Brucella Serology. Blood was collected from the jugular
vein of each animal at the time of breath collection to perform
standard serologic testing for brucellosis and blood culture.
Blood samples were placed in two 10 mL clot tubes and one 7 mL
heparinized tube. Serum was collected after centrifugation.
Both whole blood and serum were stored at −70 °C until
shipment for testing. Testing was done at the Montana State
Veterinary Diagnostic Laboratory, Bozeman, MT and/or at the
USDA-APHIS National Veterinary Services Laboratory in
Ames, Iowa. Serologic tests included fluorescence polarization
assay, complement fixation test, rivanol test, card test, buffered
acidified plate antigen test, and standard plate agglutination
test. Procedures for the isolation of Brucella bacteria from
whole blood, as well as subsequent biochemical identification,
has been described in Alton et al.21
Breath Sample Collection. Breath was collected from the
17 bison at WRF in April 2012 and the 21 bison at BQF in May
2012. Bison were restrained in a squeeze chute and breath
samples were collected by use of a mask and pump as described
in Peled et al.,9 with a few modifications. Briefly, a modified
equine nebulization mask (Aeromask, Trudell Medical Interna-
tional, London, ON, Canada) was used for breath sample
collection. Breath samples were collected using a vacuum pump
(AirChek XR5000, SKC Inc., Eighty Four, PA). Breath was
drawn through a 5 cm section of Tygon tubing (3/8 in. o.d.,
1/4 in. i.d.) (Saint-Gobain Performance Plastics, Akron, OH)
emerging from the mask, followed by a three-piece bioaerosol
cassette (SKC Inc., Eighty Four, PA) containing a 37 mm,
0.22 μm PTFE filter (Tisch Scientific, North Bend, OH) and a
37 mm cellulose pad (SKC Inc. Eighty Four, PA), followed by a
20 cm section of Tygon tubing connecting a glass cartridge
containing inert sorbent material (Tenax; SKC Inc. Eighty
Four, PA), followed by a 20 cm section of Tygon tubing leading
to the pump. The mask was held over the animal’s muzzle and
breath samples were collected at a rate of 1 L/min for 2 min. A
total of three Tenax cartridges were collected from each animal.
Three ambient air samples were collected at 1 L/min for 2 min
at the beginning of collection, after approximately half of the
animals were sampled, and at the end of sampling.
In January 2013, breath samples were collected from 19 of
the 21 bison previously sampled at BQF in 2012. The second
collection occurred after they had been transported to Sites 1
and 2 using a moderately different system than that described
above. Bison were restrained in a squeeze chute and allowed to
breathe freely into a plastic reservoir with an approximate
volume of 40 L. After four exhalations, the reservoir was sealed.
Three separate reservoirs were filled per animal. The reservoirs
were then transported to a vehicle whose interior temperature
remained between 8 and 13 °C. The reservoir contents were
then collected via the same tubing/filter/Tenax/pump
apparatus described above. One Tenax was used per reservoir,
and reservoir contents were collected for 2 min at 2.4 L/min.
At each site, three air samples were collected from a clean 40 L
reservoir for 2 min at 2.4 L/min at the beginning of collection,
after approximately half of the animals were sampled, and at the
end of sampling. Following each collection event, the Tenax
cartridges were sealed and stored at −70 °C until shipment for
GC/MS and NA-NOSE analyses.
Gas Chromatography/Mass-Spectrometry (GC/MS).
Chemical analysis of exhaled breath and air samples was
performed using gas chromatography/mass-spectrometry (GC/
MS; GCMS-QP2010, Shimadzu Corporations, Japan), com-
bined with a thermal desorption (TD) system (TD20;
Shimadzu Corporation). A SLB-5 ms capillary column was
used (5% phenyl methyl siloxane; 30 m length; 0.25 mm
internal diameter; 0.5 μm thicknesses; from Sigma-Aldrich Ltd.,
Rehovot, Israel). Prior to the analysis, the sorbent material from
each separate Tenax sorbent cartridges was transferred to a
precleaned glass TD tube (Sigma-Aldrich; compatible with the
TD system). The TD tubes were injected into the GC-system
in splitless mode at 30 cm/s constant linear speed and under
0.70 mL/min column flow; oven temperature profile: (a) 10 min
at 35 °C, (b) 4 °C/min ramp until 150 °C, (c) 10 °C/min
ramp until 300 °C, and (d) 15 min at 300 °C. The TD
temperature was set to 250 °C. The measured GC/MS
chromatograms were analyzed using the postrun analysis
program for GC/MS (GCMS solutions version 2.53SU1,
Shimadzu Corporation); the compounds were tentatively
identified via spectral library match, using the compounds
library of the National Institute of Standards and Technology
(NIST; Gaithersburg, MD). Confirmation of compound
identity and compound quantification were performed through
measurements of external standards (heptanal, 2-ethyl hexanol,
acetophenone, benzaldehyde, octanal; all from Sigma-Aldrich,
Israel). The gaseous standards were produced using a
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commercial permeation/diffusion tube dilution (PDTD)
system (Umwelttechnik MCZ, Germany); purified dry N2
(99.9999%) from a commercial N2 generator (N-30, On Site
Gas Systems; equipped with an N2 purifier) was used as carrier
gas. A temperature controlled oven (Dynacal, VICI Metronics,
Poulsbo, WA) was used to mix a constant mass flow of the
vaporized VOC of interest with a constant flow (100 ± 1 cm3/min)
of purified N2. The VOC/N2 mixture exiting the PDTD
system was diluted again with purified N2 to achieve the desired
concentrations ranging from single ppbv to several ppmv,
depending on the VOC. The VOC concentration was set by (i)
controlling the diffusion tubes’ temperature; (ii) controlling the
mass flow rate of the vaporized VOC; and (iii) controlling the
total N2 volume flow rate. The calibration gas mixtures were
pumped through Tenax sorbent cartridges of the same type as
were used for the exhaled breath and ambient air sampling at a
rate of 1 L/min for 2 min. The calibration samples were
analyzed under the same experimental conditions as the breath
samples.
Contaminants of the Tenax sorbent material were identified
through GC/MS analysis of pristine Tenax material from
unused Tenax sorbent cartridges. Five VOCs (tentatively
identified by spectral library match as methylene chloride,
acetaldehyde, L-cysteine sulfonic acid, malonic acid, and
naphthalene) were identified and are most likely contaminants
of the Tenax sorbent material. These compounds were
disregarded in the subsequent comparative analysis.22
Volatile organic compounds with a high tendency to break-
through (e.g., ethanol, pentene) were also excluded during the
data analysis.
Nanomaterial-Based Sensor Array. An array of nano-
material-based sensors was used to derive patterns indicative of
Brucella. The sensor array was comprised of cross-reactive, but
chemically diverse chemiresistors that were based on two types
of nanomaterials: (i) organically functionalized spherical gold
nanoparticles (GNPs, core diameter, 3−4 nm), and (ii) single-
walled carbon nanotubes (SWCNTs). The chemical diversity of
the sensors was achieved through 21 different organic
functionalities, 10 for the GNP sensors and 11 for the
SWCNT sensors (see Supporting Table S1 in the Supporting
Information).
The organically functionalized GNPs were synthesized as
described in refs 18, 23, and 24 and dispersed in chloroform,
toluene, or nonane. Chemiresistive layers were formed by drop-
casting the solution onto 10 pairs of semicircular interdigitated
(ID) gold electrodes (outer diameter of electrode area, 3 mm;
electrode width, 20 μm; electrode-separation, 20 μm) on device
grade silicon wafers (Silicon Quest International, Nevada) with
1 μm thermal oxide. The device was dried for 2 h at room
temperature in ambient atmosphere and then baked overnight
in a vacuum oven at 50 °C. In these layers, the GNPs’ gold
cores enabled electric transduction and the organic ligands
provided broadly cross-selective absorption sites for the breath-
VOCs. The SWCNTs were purchased from ARRY Interna-
tional LTD, Germany (∼30% metallic, ∼70% semiconducting,
average diameter = 1.5 nm, length = 7 mm) and were dispersed
in dimethylformamide (DMF, from Sigma Aldrich Ltd., >98%
purity). Electrically continuous random networks of SWCNTs
(RN-SWCNTs) were formed, as described in refs 25 and 26 by
drop-casting the solution onto the preprepared electrical
transducers (10 pairs of 4.5 mm wide, interdigitated Ti/Pd
electrodes on device grade silicon wafers (Silicon Quest
International, Nevada) with 1 μm thermal oxide. The devices
were dried under ambient conditions overnight to evaporate
the solvent. The following day the RN-SWCNTs were
organically functionalized with different cap-layers organic
monomer, sulfated β-cyclodextrin, polycyclic aromatic hydro-
carbon (PAH) derivatives, and hexabenzocoronene (HBC)
derivatives (see Supporting Table S1 in the Supporting
Information) and were again dried under ambient condi-
tions.25,26 The fabricated GNP and SWCNT sensors responded
rapidly and reversibly to typical breath-VOCs and had low
sensitivity to water.20,25,26
The TD tubes containing Tenax were inserted into a stain-
less steel chamber (volume, 400 mL; preheated to 270 °C); the
samples were thermally desorbed at 270 °C for 10 min
inside the chamber; thereafter the gas was inserted into the
vacuumed exposure chamber (containing the array of sensors).
The electrical resistance of the sensors was recorded as a
function of time by an Agilent 34980A multifunction switch
device. The AC voltage to the sensors (0.2 V at a frequency of
1 kHz) was supplied by a SR830 DSP lock-in amplifier controlled
by an IEEE 488 board. Before each measurement, the chamber
was cleaned with a 5 min vacuum procedure (>50 mtorr). In a
typical exposure cycle, the sensors’ baseline responses (R0)
were recorded for 5 min in vacuum, followed by 5 min under
exposure to the breath sample, followed by another 5 min in
vacuum. The resistance response of the sensors to the breath
samples was rapid and reversible. Four normalized sensing
features were extracted from the time-dependent resistance
response, as illustrated in Supporting Figure S1 in the
Supporting Information: (i) normalized resistance response at
the beginning of the signal, (ΔR/R0)BEG; (ii) normalized
resistance response in the middle of the signal, (ΔR/R0)MID;
(iii) normalized resistance response at the end of the signal,
(ΔR/R0)END; and (iv) area under the curve, AUC. We have
verified that the sensors’ baseline resistances did not fluctuate
or shift during the measurement period, indicating stable sens-
ing performance (see Supporting Figure S2 in the Supporting
Information).
Statistical Analysis: GC/MS. Binary comparisons between
all 20 Brucella-seropositive bison and all 18 negative controls
(from WRF and BQF) were performed for each tentatively
identified compound by means of nonparametric Wilcoxon/
Kruskal−Wallis rank sum tests at a significance level of p <
0.05.27 The statistical tests were performed using SAS JMP,
version 8.0 (SAS Institute Inc., Cary, NC, 1989−2005).
Statistical Analysis: Sensor Array. Each of the 20 sensors
in the array responded to all or to a subset of the breath-VOCs.
Models were created according to the different groups present
(i.e, Brucella-seropositive vs -seronegative samples) and were
derived from the collective resistance responses, using
discriminant factor analysis (DFA). Discriminant factor analysis
is a linear supervised pattern recognition method that
effectively reduces multidimensional experimental data, in
which the classes that should be discriminated are defined
before the analysis is performed. Additionally, DFA served as a
heuristic for selecting the most relevant sensing features and
filtering out noncontributing ones. Selection of a certain set of
sensing features was directly derived from their ability to
identify the suspected brucellosis-patterns. The DFA input
variables were the four sensing features that were obtained from
the time-dependent response of each sensor, as described
above. From these linear combinations were determined such
that the variance within each class was minimized and the
variance between classes was maximized. The DFA output
Analytical Chemistry Article
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variables (i.e., canonical variables) were obtained in mutually
orthogonal dimensions; the first canonical variable (CV1) had
the most powerful discriminating power. The classification
success was estimated through leave-one-out cross-validation in
terms of the number of true positive (TP), true negative (TN),
false positive (FP), and false negative (FN) predictions. Given
n measurements, the model was computed using n − 1 training
vectors. The validation vector that was left out during the
training phase was then projected onto the model, producing a
classification result. All possibilities of leaving-one-sample-out
were considered, and the classification accuracy was estimated
as the averaged performance over the n tests. DFA and data
classification were conducted using MATLAB (The Math-
Works).
■ RESULTS AND DISCUSSION
Chemical Analysis of Exhaled Breath. During the first
phase of the experiment, 38 breath samples from 20
seropositive and 18 seronegative bison (collected during
April/May 2012; 17 bison from the WRF; 21 from the BQF)
were chemically analyzed as described in GC/MS to explore
potential relationships between the VOCs and Brucella
seropositivity/seronegativity.
Five VOCs were excluded ab initio because they were known
contaminants of the Tenax material in the collection tubes:
methylene chloride, L-cysteine sulfonic acid, malonic acid,
acetaldehyde, and naphthalene. These VOCs had previously
been tentatively identified in the GC/MS chromatogram of
pristine Tenax.28 Signatures of 158 VOCs were observed by
GC/MS in at least one of the individual breath samples; 150 of
these were present in >85% of the 38 breath samples. While
attempting to identify these 150 VOCs by spectral library
match (NIST), we applied a similarity criterion of greater than
90%. This resulted in exclusion of 74 VOCs due to their low
similarity to the tabulated information, emphasizing the
limitations in using existing databases. Shapiro−Wilcoxon
tests demonstrated that the null hypothesis for normal
distribution of the GC/MS data was not fulfilled for the 76
remaining compounds. The binary comparative analysis
between the seropositive and seronegative states was performed
using nonparametric Wilcoxon/Kruskal−Wallis tests. Statisti-
cally significant differences in the concentration profiles of six
VOCs were observed when comparing their abundance
(normalized peak areas), using a cutoff value of p = 0.05.
One of these compounds (tentatively, styrene) was excluded
after comparison with the ambient air samples because it was
found in very high concentration (2 orders of magnitude higher
than in the breath samples) in the ambient air at both sampling
locations. The identity of the five remaining statistically
significant VOCs (2-ethyl-1-hexanol, acetophenone, octanal,
heptanal, and benzaldehyde; Table 1) were tentatively
confirmed and their absolute concentrations determined by
measuring external high-purity standards. We observed that the
average concentrations of all significant VOCs present in the
exhaled breath of the seropositive bison was generally lower
than in the breath of the seronegative controls. However, the
VOC concentrations in the ambient air samples were of the
same order of magnitude as the concentration of all compounds
found in the breath samples. All statistically significant VOCs
(2-ethyl-1-hexanol, acetophenone, octanal, heptanal, and
benzaldehyde) shared the same concentration profile: sero-
negative controls > ambient air > seropositive states. Further
systematic studies are required to confirm the trends that were T
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observed in this pilot study and to clarify their biochemical
origin. Heptanal could be of endogenous origin, since it has
been found in the headspace of bison muscle,1 bovine milk,29
and in raw and extruded bovine rumen.30 Octanal and
acetophenone have been previously observed in bovine breath
samples by others,31 2-ethyl-1-hexanol have been detected in
cattle rumen headspace,32 and benzaldehyde have been known
to be present in dairy cows and/or their waste,33 consequently
any of those materials could have metabolic relevance.
Although these compounds cannot be attributed to a specific
host/agent activity or response, the observed differences in the
concentrations of the five statistically significant VOCs may
reflect changes in VOC production related to the infection
process. In addition, we cannot with absolute certainty exclude
the possibility that the identified compounds are of exogenous
origin and that the observed concentration differences are a
coincidental outcome of the applied statistical analysis.
In the second phase of the experiment, we derived collective
patterns from the same 38 breath samples (20 seropositive and
18 seronegative bison) that were chemically analyzed, using an
array of 21 broadly cross-reactive nanomaterial-based sensors
(see Supporting Table S1 in the Supporting Information) and
the statistical algorithm DFA, as described in the sections
Nanomaterial-Based Sensor Array and GC/MS. Several
potential sensing feature combinations were identified that
appeared to distinguish between seropositive and seronegative
states. The observation of multiple possibilities for DFA models
with similar discriminative power increases the reliability of the
separation between the two states. Figure 1a shows a
representative example for a DFA model (viz. DFA model 1,
based on 4 sensing features from three GNP sensors, see
Supporting Table S1 in the Supporting Information) with good
discriminative power. The CV 1 output parameters of DFA model
1 formed well-defined and well-separated clusters for the
seropositive and the seronegative states (see Figure 1a). The
statistical classification success of model 1 was derived by leave-
one-out cross validation, as described in the section GC/MS and is
listed in Table 2. Classification results achieved sensitivity,
specificity, and accuracy levels, 72%, 90%, and 82%, respectively.
In order to study the possible confounding effect of the
bison’s environment, DFA model 1 was then applied to
separating the breath samples collected at the WRF from the
ones collected at the BQF. Figure 1b shows that the CV1 values
for the two locations overlapped strongly and leave-one-out
cross validation yielded arbitrary classification results. This
indicates that the discriminative power of the derived DFA
model for Brucella seropositivity in bison was not affected by
the animals’ environment. This feature is highly relevant for
developing a future universally applicable breath test.
Figure 1c provides a second example for a DFA model with
good discriminative power for 11 seropositive and 10 seronegative
bison from a uniform environment (BQF sample collection, May
2012), based on three sensing features from two different types of
sensors (one GNP sensor and one SWCNT sensor; see
Supporting Table S1 in the Supporting Information). Well-defined
and well-separated CV 1 clusters were again observed for the two
states (see Figure 1c). However, interestingly, the maximal overall
classification success that could be achieved was not higher than
for the mixed cohort from two different environments (accuracy,
81%). This further validates the universal applicability of the
developed method.
In the third phase of this study we investigated the stability of
the method’s discriminative power and its insensitivity to the
local environment over time. In addition, we studied the
tolerance of the approach against variation of the breath sample
Figure 1. Distribution of the first canonical variable obtained by
discriminant factor analysis (DFA). (a) DFA model 1 discriminating
between seropositive (n = 20) and seronegative (n = 18) bison.
Samples were collected April/May 2012 at the Wildlife Research
Facility (WRF) and the Bison Quarantine Facility (BQF); (b) DFA
model 1 not distinguishing between the collection sites (WRF and
BQF); (c) DFA model 2 discriminating between seropositive (n = 11)
and seronegative (n = 10) bison from the BQF only (May 2012); (d)
DFA model 3 discriminating between the follow-up breath samples
(collected January 2013 from 19 of the original 21 BQF bison that
were transferred to Sites 1 and 2) of seropositive (n = 10) and
seronegative (n = 9) bison; (e) DFA model 2 not distinguishing
between Site 1 and Site 2.
Table 2. Success of Statistical Classification of Brucella-Seropositive and Seronegative Bison Using Discriminant Factor Analysis
Models Represented in Figure 1, Derived by Leave-One-Out Cross Validationa
DFA
model target group control group
no. of
animals TN FP FN TP
sensitivity
(%)
specificity
(%)
accuracy
(%)
1 seropositive bison
(WRF and BQF, April/May 2012)
seronegative bison
(WRF and BQF, April/May 2012)
38 18 2 5 13 72 90 82
2 seropositive bison (BQF, May 2012) seronegative bison (BQF, May 2012) 21 8 3 1 9 90 73 81
3 seropositive bison
(sites 1 and 2, January 2013)
seronegative bison
(sites 1 and 2, January 2013)
20 9 1 1 8 89 90 89
aFN, false negative; FP, false positive; TN, true negatives; TP, true positives; sensitivity = TP/ (TP + FN); specificity = TN/ (TN + FP); accuracy =
(TP + TN)/(TP + TN + FN + FP).
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volume. Figure 1d presents the separation between the
seropositive and -negative states, using breath samples that
were collected 8 months later, in January 2013, from 19 of the
21 previously tested bison at the BQF. The herd had been
separated in July 2012, after the first breath collection, into two
groups of mixed seropositive and seronegative animals, and had
been transferred, with the exception of two animals (1 positive
and 1 negative) to two sites north of the BFQ. The DFA
statistical treatment yielded again multiple possibilities of
sensing feature combinations with good discriminative power.
However, we could not achieve the maximal discriminative
power by applying the DFA models 1 or 2 from the previous
analysis. This could be due to the differences in the sampling
procedure, especially the increased breath sample volume (2 L
in May 2013; 4.8 L in January 2013). Figure 1d depicts the
well-separated CV 1 clusters of the two states that were
obtained using a representative DFA model providing maximal
discrimination (based on three sensing features from one GNP
sensor and two SWCNT sensors). Good classification success
after cross-validation was achieved in this case as well
(sensitivity, specificity, and accuracy, 89%, 90%, and 89%,
respectively; see Table 2). The slightly better overall accuracy
of DFA model 3 could be due to physiological factors, such as
extent of infection and gestation stage, causing more
pronounced VOC profiles. Chemical analysis was not
performed for the follow-up breath samples because of the
relatively small sample size.
Attempting to separate with DFA model 3 the bison according
to their location (sites 1 and 2) did not succeed: The CV 1 values
of the two sites overlapped (see Figure 1e) and the classification
success after cross-validation was arbitrary. These results indicate
that the discriminative power of the tested nanomaterial-based
sensor and the insensitivity of the method to the animals’ local
environment were stable over time. Variation of the breath testing
protocol might require adjusting the sensing features but does not
seem to impede discrimination of seropositive and seronegative
animals.
■ SUMMARY AND CONCLUSIONS
Brucellosis causes the livestock industries great losses in time,
resources, and money.1 We have presented a feasibility test of a
new method for identifying Brucella-seropositive bison that is
based on profiling of VOCs in the animals’ exhaled breath. A
point-of-care diagnostic method that utilized an array of
nanomaterial-based sensors combined with a statistical
algorithm could identify well-separated patterns with good
discriminative power and predictive capability for Brucella
exposure. We demonstrated that the VOC patterns were not
affected by the animals’ environment, by including bison herds
from different locations. We further demonstrated that the
discriminative power of the approach and the insensitivity to
the environment were stable over a time span of at least
8 months. Complementary quantitative chemical analysis identi-
fied five VOCs that were statistically significantly different in
the concentration profiles of Brucella-seropositive bison versus
controls. However, attributing these five VOCs to specific host
responses to infection or agent−host interactions is beyond the
scope of this pilot study. More systemic work is needed to
understand the metabolic processes in individual host and
bacterium species and the alterations that result when exposure
or infection occurs.
The VOC concentration profiles and collective VOC
patterns that were identified in this pilot study could form
the basis for the development of a novel diagnostic test to
quickly detect Brucella-seropositive animals chute-side, pen-
side, or even remotely in populations of free-ranging ungulates.
However, the limited sample size of this study impedes far
reaching conclusions at the preset stage. The promising
preliminary results presented here support future work in the
form of a large scale trial in order to validate the proposed
method.
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H. Langmuir 2009, 25, 5411.
(27) Wilkoxon, F. Biomet. Bull. 1945, 80.
(28) Amal, H.; Ding, L.; Liu, B. B.; Tisch, U.; Xu, Z. Q.; Shi, D. Y.;
Zhao, Y.; Chen, J.; Sun, R. X.; Liu, H.; Ye, S. L.; Tang, Z. Y.; H., H. Int.
J. Nanomed. 2012, 7, 4135.
(29) Weidong, M. A.; Clement, B. A.; Klemm, W. R. J. Dairy Sci.
1997, 80, 3227.
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